-
Product Insights
Type 1 Diabetes (Juvenile Diabetes) Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2020" provides an overview of Type 1 Diabetes (Juvenile Diabetes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Sector Analysis
Type 2 Diabetes - Epidemiology Forecast to 2028
Type 2 diabetes (T2D), formerly known as non-insulin-dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency (World Health Organization, 2016a). T2D constitutes approximately 90–95% of all diabetes cases around the world, while type 1 diabetes (T1D) and gestational diabetes make up the remaining 5–10% of the cases (International Diabetes Federation, 2014). GlobalData epidemiologists utilized historical data obtained from...
-
Product Insights
Metabolic Syndrome Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Metabolic Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Metabolic Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials onMetabolic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Pre-Diabetes Impaired Glucose Tolerance Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Pre-Diabetes Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2020" provides an overview of Pre-Diabetes Impaired Glucose Tolerance Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Diabetes Impaired Glucose Tolerance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
Type 1 Diabetes: Competitive Landscape to 2026
Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin. T1D can develop at any age, but is frequently observed in children and adolescents. This report provides an assessment of the pipeline, clinical, and commercial landscape of T1D. Overall, GlobalData expects new insulins and SGLT inhibitor approvals to drive T1D market growth during the next decade.
-
Product Insights
Amyloidosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H2, 2018" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Pompe Disease: Epidemiology Forecast to 2027
Pompe disease is a rare multisystem disorder caused by pathogenic variations in the GAA gene, which contains the information for production and function of a protein called acid alpha-glucosidase (GAA). Because of the shortage of this protein (an enzyme), a complex sugar named glycogen cannot be degraded to a simple sugar like glucose. This causes the glycogen to accumulate in all kinds of tissues, but primarily in skeletal muscle, smooth muscle, and cardiac muscle, where it causes damage to tissue...
-
Product Insights
Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2018" provides an overview of Pituitary ACTH Hypersecretion (Cushing Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Pituitary ACTH Hypersecretion (Cushing Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Pompe Disease Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2018" provides an overview of Pompe Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2018" provides an overview of Post Menopausal Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Post Menopausal Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.